Volume | 109,747 |
|
|||||
News | - | ||||||
Day High | 0.56 | Low High |
|||||
Day Low | 0.5046 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Kiora Pharmaceuticals Inc | KPRX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.5078 | 0.5046 | 0.56 | 0.545 | 0.5026 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
268 | 109,747 | US$ 0.5220658 | US$ 57,295 | - | 0.45111 - 4.25 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:58:00 | 5 | US$ 0.53 | USD |
Kiora Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
13.98M | 25.88M | - | 0 | -13.05M | -0.50 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Kiora Pharmaceuticals News
Date | Time | Source | News Article |
---|---|---|---|
2/28/2024 | 15:40 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
2/14/2024 | 15:55 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
2/14/2024 | 14:51 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities |
2/13/2024 | 19:08 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
2/12/2024 | 16:23 | Edgar (US Regulatory) | Form 8-K - Current report |
2/09/2024 | 15:16 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
2/06/2024 | 09:27 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
2/01/2024 | 06:01 | Edgar (US Regulatory) | Form 8-K - Current report |
1/31/2024 | 16:14 | Edgar (US Regulatory) | Form 8-K - Current report |
1/16/2024 | 16:16 | Edgar (US Regulatory) | Form 8-K - Current report |
11/09/2023 | 06:02 | Edgar (US Regulatory) | Form 8-K - Current report |
11/09/2023 | 06:01 | Edgar (US Regulatory) | Form 8-K - Current report |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KPRX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.507 | 0.56 | 0.469 | 0.4924835 | 137,869 | 0.023 | 4.54% |
1 Month | 0.591 | 0.64 | 0.45111 | 0.5600326 | 235,006 | -0.061 | -10.32% |
3 Months | 0.77 | 0.85 | 0.45111 | 0.6359452 | 295,158 | -0.24 | -31.17% |
6 Months | 0.59 | 0.998 | 0.45111 | 0.7885725 | 880,093 | -0.06 | -10.17% |
1 Year | 4.25 | 4.25 | 0.45111 | 0.7763842 | 570,038 | -3.72 | -87.53% |
3 Years | 2.03 | 10.39 | 0.1215 | 1.15 | 1,878,904 | -1.50 | -73.89% |
5 Years | 2.03 | 10.39 | 0.1215 | 1.15 | 1,878,904 | -1.50 | -73.89% |
Kiora Pharmaceuticals Description
Kiora Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye. It operates in one reportable segment operations and manages. |